Collectively, mir-27 elevated Notch1 expression by targeting NEDD4 and promoted the development of multiple myeloma by inhibiting cell autophagy, thus providing a scientific basis for innovative treatment of multiple myeloma [64]. The gene discussed is NOTCH1; the disease is plasma cell myeloma.